Registration Document - Pernod Ricard
Registration Document - Pernod Ricard
Registration Document - Pernod Ricard
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
6 Presentation<br />
158<br />
COMBINED (ORDINARY AND EXTRAORDINARY) SHAREHOLDERS’ MEETING<br />
of the resolutions<br />
It is proposed that, by voting on the 10th, 11th and 12th resolutions,<br />
you appoint Mr. Gérald Frère, Mr. Michel Chambaud and Mr. Anders<br />
Narvinger as new Directors, replacing Mr. Didier Pineau- Valencienne,<br />
Mr. Gérard Théry and Mr. William H. Webb. The latter, whose terms of<br />
office as Directors expire with this meeting, have decided not to seek<br />
their renewal.<br />
The presentation notices of Mr. Gérald Frère, Mr. Michel Chambaud and<br />
Mr. Anders Narvinger appear in the section “Corporate Governance<br />
and Internal Control” herein.<br />
In accordance with our bylaws, Danièle <strong>Ricard</strong>, Société Paul <strong>Ricard</strong><br />
SA , Jean-Dominique Comolli, Lord Douro, Mr. Gérald Frère, Mr. Michel<br />
Chambaud and Mr. Anders Narvinger would be appointed for a term<br />
of four years expiring at the close of the Shareholders’ Meeting to<br />
be held in 2013 to approve the financial statements for the previous<br />
financial year.<br />
Directors’ fees<br />
The purpose of the 13th resolution is to set the aggregate amount of<br />
Directors’ fees allocated to the Board of Directors for the financial year<br />
in progress at €750,000. This amount is identical to that allocated for<br />
the previous financial year.<br />
Repurchase of shares<br />
As the authorisation granted to the Board of Directors by the<br />
Shareholders’ Meeting on 5 November 2008 to trade in the Company’s<br />
shares is due to expire this year, we propose, in the 14th resolution,<br />
that you renew for a period of 18 months, the authorisation for the<br />
Board of Directors to trade in the Company’s shares at a maximum<br />
purchase price set at €90 per share, excluding acquisition costs.<br />
This authorisation would enable the Board of Directors to purchase<br />
Company shares representing up to 10% of the Company’s share<br />
capital, with a view to:<br />
◆ allocating them to employees and/or D irectors (allocation of call<br />
options and free shares, coverage of its commitments pursuant to<br />
options with cash payments);<br />
◆ using them within the scope of external growth transactions (for<br />
up to 5% of the number of shares comprising the share capital);<br />
◆ delivering shares upon the exercise of rights attached to securities<br />
granting access to the share capital;<br />
◆ cancelling them;<br />
◆<br />
stabilising the share price through liquidity agreements.<br />
It should be noted that during a public offer period concerning<br />
Company shares, repurchasing transactions would only be possible<br />
on the condition, on the one hand, that the offer is settled in cash<br />
and, on the other hand, that it is within the scope of a programme<br />
currently in progress and not likely to cause the offer to fail. In<br />
addition, only repurchases that allow the Company to comply with<br />
its prior commitments would be permitted, i.e. with the objective<br />
of either allowing the Company to implement or cover stock option<br />
programmes or granting of free shares for employees and members<br />
of the Board of the Group, or delivering shares when the right to<br />
securities giving access to the Company’s capital is exercised or<br />
honouring commitments undertaken in the context of external<br />
growth operations that were concluded previously. These operations<br />
would take place under the supervision of the AMF and in compliance<br />
with the conditions of Article 232-17 of its General Regulations.<br />
PERNOD RICARD<br />
Consequently, they could not under any circumstances be anti-takeover<br />
bid (OPA) measures.<br />
Resolutions presented to the<br />
Extraordinary Shareholders’<br />
Meeting<br />
The delegations of authority subject to your vote at this Shareholders’<br />
Meeting cancel and replace, from the date of the Shareholders’ Meeting,<br />
those granted previously and having the same subject.<br />
Reduction of the share capital<br />
by cancelling treasury shares<br />
Among the aims of the share repurchase programme (14th resolution),<br />
features the cancellation of the purchased shares. For this purpose,<br />
we ask you, by voting in favour of the 15th resolution, to authorise<br />
the Board of Directors for a period of 26 months, to cancel all or<br />
some of the Company shares purchased through a share repurchase<br />
programme, for up to 10% of the shares comprising the Company’s<br />
share capital per 24-month period.<br />
Delegations of authority with a view<br />
to issuing ordinary shares or securities<br />
granting access to the Company’s<br />
capital with maintenance of preferential<br />
subscription rights (16th resolution)<br />
or cancellation of preferential subscription<br />
rights (17th resolution)<br />
16th resolution (issues of shares with<br />
preferential subscription rights)<br />
In order to continue its growth strategy and to have at its disposal<br />
means adapted to the Group’s development, your Board of Directors<br />
puts forward resolutions for you to grant it the delegations of authority<br />
for the purpose of issuing securities under current regulations.<br />
The 16th resolution concerns issues, with maintenance of your<br />
preferential subscription right, of your Company’s shares, or<br />
securities granting access to the capital (e.g. convertible bonds, share<br />
warrants).<br />
The maximum nominal amount of the share capital increases likely<br />
to be realised by virtue of this authorisation would be fixed at<br />
€200 million.<br />
It also involves deducting from the Maximum Overall Limit the<br />
share issues determined by virtue of the 17th (issue of securities with<br />
cancellation of the Preferential Subscription Right ), 18th (increase in<br />
the number of securities issued), 19th (compensation of contributions<br />
in kind), 20th (public offer of exchange initiated by the Company),<br />
22nd (capitalisation of reserves) and 25th (share capital increases<br />
reserved for employees) resolutions.<br />
The maximum nominal amount of securities representing debts<br />
(granting access to the capital) on the Company that can be issued by<br />
virtue of this authorisation would be limited to €5 billion.<br />
I REFERENCE DOCUMENT 2008/2009 I